methotrexate has been researched along with Heart Failure in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (20.00) | 18.7374 |
| 1990's | 2 (5.00) | 18.2507 |
| 2000's | 14 (35.00) | 29.6817 |
| 2010's | 11 (27.50) | 24.3611 |
| 2020's | 5 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Flynn, B; Haeger-Overstreet, K; Shah, S | 1 |
| Tschöpe, C; Van Linthout, S | 1 |
| Ahlers, MJ; Bradham, W; Chung, CP; Farber-Eger, E; Gupta, DK; Lowery, BD; Ormseth, MJ; Stein, CM; Wang, TJ | 1 |
| Chen, W; Fang, L; Lin, X; Liu, Y; Pang, H; Wang, Q; Zhang, S; Zhu, Y | 1 |
| Chen, J; Cooper, D; Norling, LV | 1 |
| Anderson, DR; Baker, JF; England, BR; George, MD; Johnson, TM; Liao, KP; Mikuls, TR; Roul, P; Sauer, B; Sayles, HR; Zheng, C | 1 |
| Kim, W; Lee, S; Seo, W | 1 |
| Akıncı, B; Aydınok, Y; Balkan, C; Karapınar, DY; Kavaklı, K; Şahin, A; Siviş, ZÖ | 1 |
| Kawaji, Y; Koshi, N; Oshiro, M; Sawada, T; Shikuma, A; Shiraishi, J; Uchiyama, H | 1 |
| Kuleva, SA | 1 |
| Okai, T; Suzuki, A; Tamamura, T | 1 |
| Aftimos, P; Ameye, L; Beauduin, M; Bejarano Hernández, S; Cornez, N; de Azambuja, E; Delhaye, F; Diaz, M; Focan, C; Lemort, M; Paesmans, M; Piccart-Gebhart, M; Shih-Li, C; Suter, T; Vandenbossche, S; Vindevoghel, A | 1 |
| Aleman, BM; Boekel, NB; Gietema, JA; Poortmans, P; Rietveld, DH; Russell, NS; Rutgers, EJ; Schaapveld, M; Schinagl, DA; Theuws, JC; van Leeuwen, FE; Versteegh, MI; Visser, O | 1 |
| Coccaro, M; Gallucci, G | 1 |
| Avorn, J; Katz, JN; Levin, R; Schneeweiss, S; Setoguchi, S; Solomon, DH; Weinblatt, ME | 1 |
| Andersen, PK; Cortese, G; Nielsen, D; Nielsen, G; Ryberg, M; Skovsgaard, T | 1 |
| Akiyoshi, K; Izumi, T; Kawano, T; Korematsu, S; Maeda, T; Miyahara, H; Sato, K; Suenobu, S; Yamada, H | 1 |
| Gottschall, CA; Moreira, DM; Vieira, JL | 1 |
| Crowson, CS; Davis, JM; Gabriel, SE; Maradit-Kremers, H; Myasoedova, E; Nicola, PJ; Roger, VL; Therneau, TM | 1 |
| Appel, JM; Christensen, HM; Ejlertsen, B; Fogh-Andersen, N; Jensen, BV; Møller, S; Nielsen, DL; Søgaard, P; Zerahn, B | 1 |
| Kim, SU; Koh, MJ; Lee, S; Park, Y | 1 |
| Clemente González, C; García Parés, D; García-Bragado Dalmau, F; Guardia Sánchez, R; Pérez Ayuso, MJ; Porcar Ramells, C | 1 |
| BLUMENSTOCK, DA; COLLINS, JA; HECHTMAN, HB; HOSBEIN, JD; JARETZKI, A; POWERS, JH; ZINGG, W | 1 |
| Fleischmann, RM; Iqbal, I; Stern, RL | 1 |
| Das, SR; Deiraniya, AK; Jha, PK; Kingston, TP; Lakshmanan, S; Musleh, GS | 1 |
| Alvegard, TA; Bacci, G; Bernini, G; Bertoni, F; Böhling, T; Brosjö, O; Capanna, R; Comandone, A; Del Prever, AB; Ferrari, S; Longhi, A; Mercuri, M; Müller, C; Picci, P; Ruggieri, P; Saeter, G; Smeland, S; Tienghi, A; Wiebe, T | 1 |
| Feng, Y; Gao, Y; Gong, K; Li, A; Luo, Q; Sun, X; Yan, J; Zhang, X; Zhang, Z | 1 |
| Avery, JK | 1 |
| Froidevaux, L; Levotanec, I; Waeber, G | 1 |
| Albain, KS; Dakhil, SR; Ganz, PA; Giguere, JK; Goodwin, JW; Hussey, MA; Hutchins, LF; Martino, S; Moinpour, CM; Unger, JM | 1 |
| Caldwell, W; Carbone, PP; Kline, JC; Loprinzi, CL; Ramirez, G; Rosenbaum, PR; Steeves, RA; Tormey, DC | 1 |
| Aukrust, P; Espevik, T; Fowler, M; Frøland, SS; Gullestad, L; Ueland, T; Vagelos, R; Yee, G | 1 |
| Akiyoshi, K; Eguchi, H; Hara, T; Inada, H; Ishii, E; Koga, H; Matsuzaki, A; Miyazaki, S; Nagatoshi, Y; Nakayama, H; Nibu, K; Okamura, J; Take, H; Tamai, Y; Yanai, F | 1 |
| Begent, RH; Hayward, JL; Knight, RK; Rubens, RD; Sexton, SA | 1 |
| Deichmann, B; Spindeldreier, A | 1 |
| Schmid, KO; Tscherne, G | 1 |
| Bessman, JD; Johnson, RK | 1 |
| Bonadonna, G; Buzzoni, R; Valagussa, P; Zambetti, M | 1 |
| Bader, J; Bagley, CS; Danforth, DN; Lippman, ME; Sorace, RA; Steinberg, SM; Swain, SM; Wesley, MN | 1 |
| Gaeta, JF; Halazun, JF; Sinks, LF; Wagner, HR | 1 |
5 review(s) available for methotrexate and Heart Failure
| Article | Year |
|---|---|
The Quest for Antiinflammatory and Immunomodulatory Strategies in Heart Failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Atherosclerosis; Calgranulin A; Calgranulin B; Cytokines; Drug Development; Heart Failure; Humans; Immunologic Factors; Inflammation; Mesenchymal Stem Cell Transplantation; Methotrexate; NLR Family, Pyrin Domain-Containing 3 Protein; T-Lymphocytes, Regulatory; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha | 2019 |
Cardiac Dysfunction in Rheumatoid Arthritis: The Role of Inflammation.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Atherosclerosis; Etanercept; Heart Failure; Humans; Hydroxychloroquine; Inflammation; Methotrexate; Myocardial Infarction; Myocardial Ischemia; Risk Factors; Stroke Volume; Sulfasalazine | 2021 |
[Primary cardiac lymphoma: cytological diagnosis and treatment with response to polychemotherapy and hematopoietic precursor autotransplant. Presentation of a case a review of the literature].
Topics: Antineoplastic Combined Chemotherapy Protocols; Atrial Flutter; Carmustine; Cyclophosphamide; Cytarabine; Doxorubicin; Echocardiography, Transesophageal; Etoposide; Heart Failure; Heart Neoplasms; Heart Septum; Hematopoietic Stem Cell Transplantation; Humans; Hydrocortisone; Immunocompetence; Injections, Spinal; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Melphalan; Methotrexate; Middle Aged; Pleural Effusion; Prednisone; Remission Induction; Tomography, X-Ray Computed; Transplantation Conditioning; Transplantation, Autologous; Vincristine | 2002 |
Considerations with the use of biological therapy in the treatment of rheumatoid arthritis.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Autoantibodies; Autoimmune Diseases; Clinical Trials as Topic; Combined Modality Therapy; Cytokines; Demyelinating Diseases; Disease Progression; Drug Therapy, Combination; Erythema; Heart Failure; Humans; Immunocompromised Host; Immunologic Factors; Interleukin-1; Methotrexate; Neoplasms; Opportunistic Infections; Tuberculosis; Tumor Necrosis Factor-alpha | 2004 |
Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Body Height; Body Weight; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Growth Disorders; Heart Failure; Hematopoietic Stem Cell Transplantation; Humans; Infant; Japan; Male; Methotrexate; Myelodysplastic Syndromes; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Survivors; Treatment Outcome; Vincristine | 2001 |
8 trial(s) available for methotrexate and Heart Failure
| Article | Year |
|---|---|
Cardiac assessment of early breast cancer patients 18 years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Echocardiography; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Heart Failure; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Prognosis; Proportional Hazards Models; Survival Rate; Ventricular Dysfunction, Left | 2015 |
The effects of METhotrexate therapy on the physical capacity of patients with ISchemic heart failure: a randomized double-blind, placebo-controlled trial (METIS trial).
Topics: Aged; Double-Blind Method; Exercise Test; Female; Follow-Up Studies; Heart Failure; Humans; Male; Methotrexate; Middle Aged; Myocardial Ischemia; Physical Endurance; Recovery of Function; Treatment Outcome | 2009 |
Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Extremities; Female; Follow-Up Studies; Heart Failure; Humans; Ifosfamide; Italy; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Patient Compliance; Prospective Studies; Renal Insufficiency; Scandinavian and Nordic Countries; Treatment Outcome | 2005 |
The nonspecific anti-inflammatory therapy with methotrexate for patients with chronic heart failure.
Topics: Anti-Inflammatory Agents; Chronic Disease; Cytokines; Female; Heart Failure; Humans; Inflammation Mediators; Male; Methotrexate; Middle Aged; Prospective Studies; Single-Blind Method | 2006 |
Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Fluorouracil; Heart; Heart Failure; Humans; Methotrexate; Middle Aged; Prognosis; Receptor, ErbB-2; Survival Rate; Survivors; Tamoxifen; Ventricular Dysfunction, Left | 2008 |
Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Chemokine CCL2; Chronic Disease; Cytokines; Double-Blind Method; Echocardiography; Enalapril; Female; Heart Failure; Heart Septum; Humans; Hypertrophy, Left Ventricular; Immunoenzyme Techniques; Interleukin-1; Interleukin-6; Male; Methotrexate; Middle Aged; Neopterin; P-Selectin; Receptors, Interleukin-6; Treatment Outcome; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 1999 |
Combined cytotoxic and progestogen therapy for advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Heart Failure; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Norethindrone; Remission, Spontaneous; Time Factors; Vincristine | 1978 |
Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Heart Failure; Humans; Infusions, Intravenous; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Survival Analysis | 1991 |
27 other study(ies) available for methotrexate and Heart Failure
| Article | Year |
|---|---|
Methotrexate-induced acute cardiotoxicity requiring veno-arterial extracorporeal membrane oxygenation support: a case report.
Topics: Cardiotoxicity; Extracorporeal Membrane Oxygenation; Heart Failure; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Stroke Volume; Ventricular Function, Left | 2022 |
Heart Failure Risk Associated With Rheumatoid Arthritis-Related Chronic Inflammation.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers; C-Reactive Protein; Electronic Health Records; Female; Heart Failure; Humans; Incidence; Inflammation Mediators; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Nerve Tissue Proteins; Prognosis; Prospective Studies; Proteomics; Retrospective Studies; Risk Assessment; Risk Factors; Tennessee; Time Factors | 2020 |
Clinical Characteristics, Treatment, and Outcomes in Patients with Idiopathic Inflammatory Myopathy Concomitant with Heart Failure.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; China; Drug Therapy, Combination; Female; Glucocorticoids; Heart Failure; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Middle Aged; Myositis; Retrospective Studies; Young Adult | 2020 |
Investigating changes in disease activity as a mediator of cardiovascular risk reduction with methotrexate use in rheumatoid arthritis.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cardiovascular Diseases; Coronary Artery Disease; Female; Heart Disease Risk Factors; Heart Failure; Hospitalization; Humans; Incidence; Male; Methotrexate; Middle Aged; Proportional Hazards Models; Stroke | 2021 |
Safe Use of Rituximab in an Elderly Patient With Rheumatoid Arthritis and Severe Heart Failure.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Echocardiography; Hand Joints; Heart Failure; Humans; Male; Methotrexate; Radiography; Rituximab; Severity of Illness Index; Stroke Volume; Time; Treatment Outcome | 2018 |
Stevens-Johnson Syndrome associated with methotrexate treatment for acute lymphoblastic leukemia: a case report.
Topics: Antimetabolites, Antineoplastic; Child; Gastrointestinal Hemorrhage; Heart Failure; Humans; Immunoglobulins, Intravenous; Male; Methotrexate; Methylprednisolone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stevens-Johnson Syndrome | 2018 |
Cardiac involvement of malignant lymphoma presenting intra-ventricular-wall nodules.
Topics: Abdominal Neoplasms; Aged; Antineoplastic Combined Chemotherapy Protocols; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclophosphamide; Doxorubicin; Female; Heart Failure; Heart Neoplasms; Heart Ventricles; Humans; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Prednisolone; Tomography, X-Ray Computed; Vincristine | 2019 |
[Delayed elimination of methotrexate after high-dose infusion].
Topics: Antimetabolites, Antineoplastic; Brain Neoplasms; Fatal Outcome; Half-Life; Heart Failure; Hemorrhage; Humans; Hyperemia; Infant; Male; Methotrexate; Mucositis; Neuroectodermal Tumors, Primitive; Pancytopenia; Respiratory Insufficiency; Sella Turcica; Skin; Time Factors | 2013 |
Five-year administration of tocilizumab to a patient with rheumatoid arthritis complicated by severe chronic heart failure.
Topics: Adult; Antibodies, Monoclonal, Humanized; Arthritis, Rheumatoid; Chronic Disease; Diagnostic Imaging; Drug Therapy, Combination; Heart Failure; Humans; Male; Methotrexate; Middle Aged; Severity of Illness Index; Time Factors; Treatment Outcome | 2014 |
Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors.
Topics: Age Factors; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Intraductal, Noninfiltrating; Cardiovascular Diseases; Cause of Death; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Combined Modality Therapy; Confidence Intervals; Female; Fluorouracil; Heart; Heart Failure; Heart Valve Diseases; Humans; Lymphatic Irradiation; Mastectomy; Methotrexate; Middle Aged; Myocardial Ischemia; Netherlands; Radiotherapy; Registries; Risk Assessment; Survivors; Time Factors; Unilateral Breast Neoplasms | 2016 |
Late cardiac effects of adjuvant radiotherapy and chemotherapy in early breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Fluorouracil; Heart; Heart Failure; Humans; Methotrexate; Middle Aged; Prognosis; Receptor, ErbB-2; Survival Rate; Survivors; Tamoxifen; Ventricular Dysfunction, Left | 2008 |
Tumor necrosis factor-alpha antagonist use and heart failure in elderly patients with rheumatoid arthritis.
Topics: Age Factors; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Confounding Factors, Epidemiologic; Female; Heart Failure; Hospitalization; Humans; Male; Methotrexate; Proportional Hazards Models; Retrospective Studies; Risk; Tumor Necrosis Factor-alpha | 2008 |
New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients.
Topics: Adult; Age Factors; Aged; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Denmark; Disease Susceptibility; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Heart; Heart Failure; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Severity of Illness Index; Tamoxifen; Vindesine | 2008 |
A relapse of systemic type juvenile idiopathic arthritis after a rubella vaccination in a patient during a long-term remission period.
Topics: Arthritis, Juvenile; Child; Female; Heart Failure; Humans; Ibuprofen; Methotrexate; Recurrence; Rubella Vaccine; Vaccination; Vaccines, Attenuated | 2009 |
The influence of rheumatoid arthritis disease characteristics on heart failure.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Female; Heart Failure; Humans; Methotrexate; Middle Aged; Risk Factors | 2011 |
Long-term heart function after adjuvant epirubicin chemotherapy for breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Breast Neoplasms; Chemotherapy, Adjuvant; Cohort Studies; Cyclophosphamide; Denmark; Drug Administration Schedule; Echocardiography; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Heart; Heart Failure; Humans; Methotrexate; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Radionuclide Ventriculography; Registries; Stroke Volume; Time Factors | 2012 |
Compensated heart failure does not always alleviate overestimation of liver stiffness by transient elastography.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Elasticity Imaging Techniques; Female; Heart Failure; Humans; Liver; Liver Cirrhosis; Methotrexate; Predictive Value of Tests; Reproducibility of Results; Risk Factors; Treatment Outcome | 2013 |
PROLONGED SURVIVAL OF ORTHOTOPIC HOMOTRANSPLANTS OF THE HEART IN ANIMALS TREATED WITH METHOTREXATE.
Topics: Allergy and Immunology; Dogs; Electrocardiography; Heart; Heart Failure; Hydrothorax; Hypoxia, Brain; Methotrexate; Pharmacology; Pulmonary Atelectasis; Research; Transplantation | 1963 |
Psoriasis-induced postoperative cardiac failure.
Topics: Aged; Dermatitis, Exfoliative; Female; Heart Failure; Humans; Methotrexate; Postoperative Complications; Psoriasis; Vasodilation | 2005 |
Be careful about what you sign.
Topics: Aged, 80 and over; Antirheumatic Agents; Female; Heart Failure; Humans; Medication Errors; Methotrexate | 2006 |
[A heart insufficiency treated by glucocorticoids].
Topics: Adult; Arrhythmogenic Right Ventricular Dysplasia; Biopsy; Cardiomyopathies; Defibrillators, Implantable; Diagnosis, Differential; Echocardiography; Electrocardiography; Glucocorticoids; Heart Failure; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Myocardium; Sarcoidosis; Time Factors; Tomography, X-Ray Computed | 2007 |
Aggressive combined modality therapy for advanced local-regional breast carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cardiomegaly; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Fluorouracil; Follow-Up Studies; Heart Failure; Humans; Mastectomy; Methotrexate; Middle Aged; Pilot Projects; Prednisone; Prospective Studies | 1984 |
[The nosology of continuing suppurative acrodermatitis Hallopeau and of psoriasis pustulosa].
Topics: Acrodermatitis; Adrenal Cortex Hormones; Aged; Female; Heart Failure; Humans; Methotrexate; Pneumonia; Psoriasis | 1979 |
Limits of therapy for malignant chorioepithelioma.
Topics: Adult; Cell Differentiation; Choriocarcinoma; Female; Heart Failure; Humans; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Pregnancy; Pulmonary Embolism | 1979 |
Erythrocyte volume distribution in normal and abnormal subjects.
Topics: Adenocarcinoma; Anemia, Hypochromic; Anemia, Macrocytic; Anemia, Pernicious; Brain Diseases; Electronics, Medical; Erythrocyte Count; Erythrocytes; Female; Folic Acid Deficiency; Heart Failure; Hematocrit; Hemorrhage; Humans; Male; Methotrexate; Middle Aged; Reticulocytes; Thrombophlebitis; Vitamin B 12 Deficiency; Warfarin | 1975 |
Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Estrogens, Conjugated (USP); Fluorouracil; Heart Failure; Humans; Leucovorin; Leukopenia; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Tamoxifen | 1987 |
Proceedings: Daunorubicin cardiac toxicity in children with acute lymphocytic leukemia.
Topics: Adolescent; Age Factors; Autopsy; Child; Child, Preschool; Daunorubicin; Drug Therapy, Combination; Edema; Electrocardiography; Female; Heart; Heart Conduction System; Heart Failure; Humans; Leukemia, Lymphoid; Male; Methotrexate; Myocardium; Myofibrils; Prednisone; Remission, Spontaneous; Vincristine | 1974 |